2019 American Transplant Congress
Use of Latent Class Analysis to Identify Patient Symptom Burden Subgroups after Living Donor Kidney Transplant
Northwestern University, Chicago, IL
*Purpose: Identifying groups of patients based on clusters of symptoms they experience may help advance our understanding of living donor kidney transplant (LDKT) recipients’ post-operative…2019 American Transplant Congress
Patient Reported Side Effects Associated with Reduced Quality of Life after Living Donor Kidney Transplant
Northwestern University, Chicago, IL
*Purpose: As living donor kidney transplant (LDKT) graft and patient survival approaches 100%, the focus of care turns to patient reported outcome measures such as…2019 American Transplant Congress
Pre-Transplant Patient and Caregiver Assessments: A Systematic Review and Meta-Analysis
*Purpose: We sought to summarize the available literature regarding the psychosocial effects of the waiting period on pre-transplant adult heart or lung transplant candidates and…2019 American Transplant Congress
Patient-Reported Transplant-Related Symptoms in Kidney Transplant Recipients
1Terasaki Research Institute, Los Angeles, CA, 2Bristol Myers Squibb, Princeton, NJ
*Purpose: Kidney transplant (txp) recipients experience many symptoms as a result of their transplant experience, immunosuppressive regimens, and comorbid conditions. The objective of this analysis…2019 American Transplant Congress
Prospective Evaluation of Living Kidney Donor Anxiety: Concerns, Anxiety Mitigation, and Realized Negative Experiences
Medicine, Indiana University Health, Indianapolis, IN
*Purpose: Living donor kidney transplantation provides a critical source of high quality grafts for patients with end stage renal disease. Detailed understanding of specific sources…2019 American Transplant Congress
Availability of Psychiatric and Chemical Dependency Treatment Services at US Hospitals Providing Transplantations
*Purpose: Comprehensive pre-transplant psychosocial assessment is recommended by organ-specific professional transplant (TX) organizations. Given the significant impact on TX outcomes of untreated psychiatric (PSYCH) comorbidities,…2019 American Transplant Congress
Belatacept Treated Patients Experience Improved Health-Related Quality of Life and Lower Symptom Distress Compared to Cyclosporine Treated Patients: An Analysis of the Benefit and Benefit-EXT Cohorts
1Terasaki Research Institute, Los Angeles, CA, 2Bristol Myers Squibb, Princeton, NJ
*Purpose: New immunosuppressive agents in transplant should not only be efficacious but also help patients feel better (i.e. lower patient reported symptoms and improve health…2019 American Transplant Congress
Predicting Deceased Donor Kidney Transplant Outcomes: Comparing KDRI/KDPI with Machine Learning
HealthTech Solutions, Inc., Coralville, IA
*Purpose: To better predict outcomes of graft survival in kidney donation and ultimately save more lives for those waiting on the list.*Methods: Machine learning methods…2019 American Transplant Congress
Evaluation Of Workplace Environment In Transplant Medicine: Harassment Should Not Be The “Reality Of Life”
*Purpose: The recent increase in publications detailing discrimination and harassment in the medical setting has brought to light potential impairments of medical professional health and…2019 American Transplant Congress
Patient-Reported Outcomes in a Prospective Multicenter Trial of Belatacept-Based CNI- and Corticosteroid-Free Immunosuppression Regimens in Kidney Transplantation
*Purpose: Previous trials have not examined differences in patient-reported outcomes (PRO) between belatacept (BELA)- and tacrolimus (TAC)-based therapies in adult kidney transplant (KTx) patients (pts).…
- « Previous Page
- 1
- …
- 8
- 9
- 10
- 11
- 12
- …
- 21
- Next Page »